Therapeutic Application of Nanotechnology in Arteriosclerosis and Atherosclerosis

A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Nanobiotechnology and Biofabrication".

Deadline for manuscript submissions: 28 February 2025 | Viewed by 1832

Special Issue Editors


E-Mail Website
Guest Editor
Department of Surgery, School of Medicine, Emory University, Atlanta, GA 30322, USA
Interests: vascular biology; regenerative medicine; vessel biomechanics

E-Mail Website
Guest Editor
Department of Surgery, School of Medicine, Emory University, Atlanta, GA 30322, USA
Interests: cardiovascular diseases; mitochondrial biology; microcirculation dysfunction

Special Issue Information

Dear Colleagues,

Atherosclerosis (AS) is a predominant risk factor for cardiovascular diseases (CVDs). The conventional treatments for AS include lipid-lowering, anti-inflammatory, and antiproliferative drugs. Though these show inhibitory effects on the development of AS, CVDs remain the leading cause of morbidity and mortality worldwide. Therefore, there is an urgent need to tackle AS from different angles to develop novel and more effective therapies. The utilization of nanotechnology for medical purposes has grown exponentially over the past few decades. Compared with conventional treatments, nanoparticle drugs exhibit significant advantages, including increased plaque-targeted drug delivery, sustained drug release, enhanced bioavailability, decreased toxicity, etc. This approach may be particularly useful in peripheral artery disease (PAD), where established cardiovascular therapies have not demonstrated local benefit in atherosclerotic burden or limb function. In addition, the collaborative treatment of nanoparticles with physical treatment (e.g., ultrasound, near-infrared lasers, and external magnetic field) also presents extra benefits in impeding the progression of AS.

This Special Issue aims to develop new insights into the perspective of nanotechnology in AS, discover new mechanisms/nano-drugs, and boost the clinically translational application of nanotechnology in CVDs, particularly PAD. Manuscripts from original research papers, comprehensive reviews, communications, and case reports are welcomed.

Dr. Luke Brewster
Dr. Fujie Zhao
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • atherosclerosis
  • nanoparticle
  • targeted delivery
  • therapeutic effect
  • peripheral artery disease

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

17 pages, 920 KiB  
Review
Nanoparticle-Based Drug Delivery for Vascular Applications
by Atanu Naskar, Sreenivasulu Kilari, Gaurav Baranwal, Jamie Kane and Sanjay Misra
Bioengineering 2024, 11(12), 1222; https://doi.org/10.3390/bioengineering11121222 - 3 Dec 2024
Viewed by 1424
Abstract
Nanoparticle (NP)-based drug delivery systems have received widespread attention due to the excellent physicochemical properties of nanomaterials. Different types of NPs such as lipid NPs, poly(lactic-co-glycolic) acid (PLGA) NPs, inorganic NPs (e.g., iron oxide and Au), carbon NPs (graphene and carbon nanodots), 2D [...] Read more.
Nanoparticle (NP)-based drug delivery systems have received widespread attention due to the excellent physicochemical properties of nanomaterials. Different types of NPs such as lipid NPs, poly(lactic-co-glycolic) acid (PLGA) NPs, inorganic NPs (e.g., iron oxide and Au), carbon NPs (graphene and carbon nanodots), 2D nanomaterials, and biomimetic NPs have found favor as drug delivery vehicles. In this review, we discuss the different types of customized NPs for intravascular drug delivery, nanoparticle behaviors (margination, adhesion, and endothelium uptake) in blood vessels, and nanomaterial compatibility for successful drug delivery. Additionally, cell surface protein targets play an important role in targeted drug delivery, and various vascular drug delivery studies using nanoparticles conjugated to these proteins are reviewed. Finally, limitations, challenges, and potential solutions for translational research regarding NP-based vascular drug delivery are discussed. Full article
Show Figures

Figure 1

Back to TopTop